Last reviewed · How we verify

NCT07233161: m-CIMT

Effectiveness of m-CIMT of the Upper Limb in Acute Post-stroke Patients. (m-CIMT, Modified Constraint-induced Movement Therapy)

Recruiting now NA Last updated 18 November 2025
What this trial tests

NA trial testing m-CIMT in Isquemic Stroke in 66 participants. Currently enrolling.

Timeline
23 April 2025
Primary endpoint
20 December 2026
20 December 2026

Quick facts

Lead sponsorHospital Clinic of Barcelona
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment66
Start date23 April 2025
Primary completion20 December 2026
Estimated completion20 December 2026
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Clinic of Barcelona

Who can join

18 and older, any sex, with Isquemic Stroke or Upper Limb Weakness Due to Central Neurologic Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

m-CIMT therapy is the restriction of the unaffected upper extremity in conjunction with an upper extremity specific exercise protocol to improve the functionality and use of the affected upper extremity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hospital Clinic of Barcelona trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07233161.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing